Cargando…

The multifaceted protease-anti-protease imbalance in COVID-19

Detalles Bibliográficos
Autores principales:	Goel, Khushboo, Serban, Karina A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947327/ https://www.ncbi.nlm.nih.gov/pubmed/35339893 http://dx.doi.org/10.1016/j.ebiom.2022.103973

Ejemplares similares

Protease–Antiprotease Imbalance in Bronchiectasis
por: Oriano, Martina, et al.
Publicado: (2021)

The Multifaceted Poliovirus 2A Protease: Regulation of Gene Expression by Picornavirus Proteases
por: Castelló, Alfredo, et al.
Publicado: (2011)

The multifaceted long-term effects of the COVID-19 pandemic on urology
por: Morlacco, Alessandro, et al.
Publicado: (2020)

The Multifaceted Role of the Lysosomal Protease Cathepsins in Kidney Disease
por: Cocchiaro, Pasquale, et al.
Publicado: (2017)

Inactivation of Lon protease reveals a link between mitochondrial unfolded protein stress and mitochondrial translation inhibition
por: Pareek, Gautam, et al.
Publicado: (2018)

The multifaceted challenge of evaluating protected area effectiveness
por: Rodrigues, Ana S. L., et al.
Publicado: (2020)

A multifaceted analysis of HIV-1 protease multidrug resistance phenotypes
por: Doherty, Kathleen M, et al.
Publicado: (2011)

Multifaceted Analyses of Epidermal Serine Protease Activity in Patients with Atopic Dermatitis
por: Nomura, Hayato, et al.
Publicado: (2020)

Multifaceted roles of flavonoids mediating plant-microbe interactions
por: Wang, Lanxiang, et al.
Publicado: (2022)

Multifaceted mechanisms mediating cystine starvation-induced ferroptosis
por: Shi, Zhennan, et al.
Publicado: (2021)

Promotion of a Protease–Antiprotease Imbalance in the Airways through Chronic Vaping
por: Martin, S. Lorraine, et al.
Publicado: (2019)

Pathogenic triad in COPD: oxidative stress, protease–antiprotease imbalance, and inflammation
por: Fischer, Bernard M, et al.
Publicado: (2011)

Comments on Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease by Dai et al.(2020)
por: Chiappelli, Francesco
Publicado: (2020)

Protease-Activated Receptor-2: A Multifaceted Molecular Transducer in the Human Skin
por: Andersen, Hjalte H.
Publicado: (2016)

Comment on “Endothelial Protein C Receptor (EPCR), Protease Activated Receptor-1 (PAR-1) and Their Interplay in Cancer Growth and Metastatic Dissemination” Cancers 2019, 11, 51
por: Pontarollo, Giulia, et al.
Publicado: (2019)

The multifaceted Q fever epidemiology: a call to implement One Health approach in Latin America
por: Fernandes, Jorlan, et al.
Publicado: (2023)

COVID-19 and the anti-lessons of history
por: Peckham, Robert
Publicado: (2020)

Ageing and smoking contribute to plasma surfactant proteins and protease imbalance with correlations to airway obstruction
por: Ilumets, Helen, et al.
Publicado: (2011)

Protease Inhibitor Use in COVID-19
por: Song, Yueqi, et al.
Publicado: (2020)

COVID-19: combining antiviral and anti-inflammatory treatments
por: Stebbing, Justin, et al.
Publicado: (2020)

Protease-anti-protease compartmentalization in SARS-CoV-2 ARDS: Therapeutic implications
por: McElvaney, Oisin F., et al.
Publicado: (2022)

The opening salvo of anti-complement therapy against COVID-19
por: Campbell, Courtney M
Publicado: (2020)

Type I interferon, anti-interferon antibodies, and COVID-19
por: Calabrese, Leonard H, et al.
Publicado: (2021)

The course of action for effective anti-cytokine treatment in COVID-19
por: Cavalli, Giulio, et al.
Publicado: (2021)

Non-steroidal anti-inflammatory drug use in COVID-19
por: Kragholm, Kristian, et al.
Publicado: (2021)

Molecular modeling evaluation of the binding effect of five protease inhibitors to COVID-19 main protease
por: Liu, Jian, et al.
Publicado: (2021)

Spotlights on ubiquitin-specific protease 12 (USP12) in diseases: from multifaceted roles to pathophysiological mechanisms
por: Niu, Kaiyi, et al.
Publicado: (2023)

Protease targeted COVID-19 drug discovery and its challenges: Insight into viral main protease (Mpro) and papain-like protease (PLpro) inhibitors
por: Amin, Sk. Abdul, et al.
Publicado: (2021)

Proteases
por: Ward, O.P.
Publicado: (2011)

Proteases
por: Ward, O.P.
Publicado: (2011)

Aspartyl Protease Inhibitors as Anti-Filarial Drugs
por: Beld, Liana, et al.
Publicado: (2022)

Use of protease inhibitors for the prevention of COVID-19
por: Sagawa, Tomoya, et al.
Publicado: (2020)

Structural dynamics of COVID-19 main protease
por: Shekaari, Ashkan, et al.
Publicado: (2021)

Is the attenuated humoral response to COVID-19 vaccination in anti-TNF users relevant?
por: Chhibba, Tarun, et al.
Publicado: (2022)

Mode switching: the state, market, and anti-Covid-19 shadow of socialism in China
por: Yan, Hairong
Publicado: (2020)

Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
por: Feldmann, Marc, et al.
Publicado: (2020)

Extracellular: Plasma Membrane Proteases – Serine Proteases
por: Antalis, T.M., et al.
Publicado: (2016)

The coagulation factor Xa/protease activated receptor-2 axis in the progression of liver fibrosis: a multifaceted paradigm
por: Borensztajn, Keren, et al.
Publicado: (2010)

Structure function characterization of SARS CoV2 proteases for COVID19 antiviral development
por: Greene-Cramer, Rebecca, et al.
Publicado: (2022)

Airway protease/antiprotease imbalance in atopic asthmatics contributes to increased Influenza A virus cleavage and replication
por: Kesic, Matthew J, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_72i64s0nkrt9mklp0cdqq8cupb